Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma

Invasive lobular breast carcinoma (ILC) accounts for 10% to 15% of breast cancers diagnosed annually. Evidence suggests that some aspects of endocrine treatment response might differ between invasive ductal carcinoma (IDC) and ILC, and that patients with ILC have worse long-term survival. We analyze...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Endocrinology
Asıl Yazarlar: Sreekumar, Sreeja, Levine, Kevin M, Sikora, Matthew J, Chen, Jian, Tasdemir, Nilgun, Carter, Dorothy, Dabbs, David J, Meier, Carolin, Basudan, Ahmed, Boone, David, McAuliffe, Priscilla F, Jankowitz, Rachel C, Lee, Adrian V, Atkinson, Jennifer M, Oesterreich, Steffi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7438704/
https://ncbi.nlm.nih.gov/pubmed/32609836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/endocr/bqaa109
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller